日本化薬の業績推移
(単位:百万円)
|
売上高 |
営業利益 |
経常利益 |
純利益 |
売上原価 |
売上総利益 |
株主資本 |
総負債 |
総資産 |
現金及び現金同等物 |
流動市場性有価証券 |
流動資産 |
流動負債 |
利益剰余金 |
営業利益率 |
経常利益率 |
当期利益率 |
自己資本比率 |
営業キャッシュフロー |
投資キャッシュフロー |
財務キャッシュフロー |
営業キャッシュフローマージン |
フリーキャッシュフロー |
ROE |
ROA |
一株あたり利益 |
希薄化後一株あたり利益 |
従業員数 |
2024年3月
|
201,791
|
7,337
|
12,562
|
4,179
|
140,490
|
61,301
|
270,548
|
92,625
|
363,173
|
56,749
|
|
203,146
|
59,815
|
199,214
|
3.64%
|
6.23%
|
2.07%
|
74.5%
|
23,242
|
-19,409
|
3,823
|
11.52%
|
3,833
|
1.59%
|
1.22%
|
0.0000248
|
0.00002479
|
5902人
|
2023年3月
|
198,380
|
21,505
|
23,025
|
15,042
|
131,627
|
66,753
|
255,027
|
67,831
|
322,858
|
48,051
|
|
186,037
|
39,049
|
202,976
|
10.84%
|
11.61%
|
7.58%
|
78.99%
|
20,039
|
-15,158
|
-7,950
|
10.1%
|
4,881
|
6.0%
|
4.71%
|
0.00008936
|
0.00008933
|
5782人
|
2022年3月
|
184,805
|
21,050
|
23,154
|
17,244
|
120,837
|
63,968
|
246,425
|
69,034
|
315,459
|
38,459
|
|
175,843
|
45,760
|
195,566
|
11.39%
|
12.53%
|
9.33%
|
78.12%
|
23,141
|
-10,641
|
-11,090
|
12.52%
|
12,500
|
7.27%
|
5.65%
|
0.0001017
|
0.00010165
|
5703人
|
2021年3月
|
173,381
|
15,194
|
16,538
|
12,590
|
117,067
|
56,314
|
228,273
|
66,262
|
294,535
|
33,306
|
|
156,852
|
37,491
|
191,606
|
8.76%
|
9.54%
|
7.26%
|
77.5%
|
24,408
|
-17,606
|
-8,402
|
14.08%
|
6,802
|
5.75%
|
4.39%
|
0.00007362
|
0.00007361
|
5664人
|
2020年3月
|
175,123
|
17,485
|
18,026
|
12,879
|
117,059
|
58,064
|
210,019
|
68,477
|
278,496
|
43,222
|
|
153,102
|
38,800
|
184,156
|
9.98%
|
10.29%
|
7.35%
|
75.41%
|
27,281
|
-17,543
|
-13,894
|
15.58%
|
9,738
|
5.87%
|
4.5%
|
0.00007425
|
0.00007423
|
5847人
|
2019年3月
|
172,639
|
19,939
|
21,608
|
15,681
|
109,461
|
63,178
|
229,043
|
64,528
|
293,571
|
42,432
|
|
161,958
|
41,412
|
182,133
|
11.55%
|
12.52%
|
9.08%
|
78.02%
|
26,803
|
-17,694
|
-6,437
|
15.53%
|
9,109
|
6.97%
|
5.4%
|
0.00008577
|
0.00008575
|
5814人
|
2018年3月
|
167,888
|
22,615
|
22,480
|
16,210
|
102,475
|
65,413
|
220,619
|
66,946
|
287,565
|
42,411
|
|
157,814
|
42,746
|
172,476
|
13.47%
|
13.39%
|
9.66%
|
76.72%
|
20,121
|
-16,171
|
-6,241
|
11.98%
|
3,950
|
7.6%
|
5.79%
|
0.00008945
|
0.00008944
|
5684人
|
2017年3月
|
159,117
|
19,646
|
19,947
|
16,377
|
95,253
|
63,864
|
205,866
|
66,925
|
272,791
|
44,596
|
|
153,602
|
41,321
|
162,615
|
12.35%
|
12.54%
|
10.29%
|
75.47%
|
31,390
|
-11,913
|
-14,103
|
19.73%
|
19,477
|
8.06%
|
6.0%
|
0.00009023
|
0.00009021
|
5517人
|
2016年3月
|
162,922
|
21,713
|
21,016
|
18,290
|
96,653
|
66,269
|
200,492
|
72,187
|
272,679
|
37,128
|
|
151,170
|
39,740
|
152,219
|
13.33%
|
12.9%
|
11.23%
|
73.53%
|
19,603
|
-5,090
|
-9,432
|
12.03%
|
14,513
|
9.14%
|
6.8%
|
0.00009609
|
0.00009606
|
5188人
|
2015年3月
|
161,861
|
22,301
|
25,162
|
16,805
|
94,664
|
67,197
|
199,680
|
65,446
|
265,126
|
36,099
|
|
141,282
|
38,915
|
139,457
|
13.78%
|
15.55%
|
10.38%
|
75.32%
|
20,263
|
-15,807
|
-12,498
|
12.52%
|
4,456
|
8.9%
|
6.56%
|
0.00008638
|
0.00008631
|
5165人
|
2014年3月
|
160,080
|
24,090
|
26,496
|
16,718
|
90,645
|
69,435
|
177,935
|
69,657
|
247,592
|
29,119
|
|
141,843
|
41,271
|
128,302
|
15.05%
|
16.55%
|
10.44%
|
71.87%
|
29,480
|
-20,187
|
5
|
18.42%
|
9,293
|
9.88%
|
7.08%
|
0.00009225
|
0.00009225
|
4794人
|
2013年3月
|
128,104
|
17,066
|
20,480
|
12,342
|
73,757
|
54,347
|
160,454
|
64,251
|
224,705
|
26,120
|
|
131,553
|
39,857
|
115,205
|
13.32%
|
15.99%
|
9.63%
|
71.41%
|
14,445
|
-11,641
|
-1,542
|
11.28%
|
2,804
|
8.11%
|
5.75%
|
0.00006809
|
0.00006806
|
4619人
|
2012年5月
|
147,109
|
|
19,916
|
11,401
|
|
|
144,019
|
60,655
|
204,674
|
37,874
|
|
|
|
|
0.0%
|
13.54%
|
7.75%
|
70.37%
|
22,791
|
-12,795
|
-13,439
|
15.49%
|
9,996
|
|
|
0.00006289
|
0.00006286
|
4583人
|
2011年5月
|
148,879
|
|
20,282
|
13,004
|
|
|
|
|
|
|
|
|
|
|
0.0%
|
13.62%
|
8.73%
|
|
|
|
|
|
|
|
|
0.0000717
|
0.0000717
|
4406人
|
2010年5月
|
141,032
|
|
16,052
|
9,871
|
|
|
|
|
|
|
|
|
|
|
0.0%
|
11.38%
|
7.0%
|
|
|
|
|
|
|
|
|
0.00005439
|
0.00005439
|
4224人
|